Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 05 December 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Waist-to-hip ratio is associated with an increased risk of Barrett's esophagus

Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men, reports the latest issue of the Clinical Gastroenterology & Hepatology.

News image

Abdominal obesity increases the risk of gastroesophageal reflux disease (GERD), and also might contribute to the development of Barrett's esophagus, although results are inconsistent.

Dr Jennifer Kramer and colleagues from Houston Texas examined the effects of waist-to-hip ratio and body mass index on the risk of Barrett's esophagus and investigated whether race, gastroesophageal reflux disease symptoms, or hiatus hernia were involved.

The team conducted a case-control study using data from eligible patients who underwent elective esophagogastroduodenoscopy.

The researchers noted that 237 patients had Barrett's esophagus, and the other 1021 patients served as endoscopy controls.

The team also analyzed data and tissue samples from enrolled patients who were eligible for screening colonoscopies at a primary care clinic.

The research team reported that all patients underwent esophagogastroduodenoscopy, completed a survey, and had anthropometric measurements taken.

Waist-to-hip ratio was categorized as high if it was 0.9 or greater for men or 0.85 or greater for women.

Patients with Barrett's were 2-fold more likely to have a high waist-to-hip ratio
Clinical Gastroenterology and Hepatology

There was no association between body mass index, and Barrett's esophagus.

The doctors noted that more patients with Barrett's esophagus had a high waist-to-hip ratio than endoscopy controls or colonoscopy controls.

In adjusted analysis, patients with Barrett's esophagus were 2-fold more likely to have a high waist-to-hip ratio than endoscopy controls, this association was stronger for patients with long-segment Barrett's esophagus.

The research team found that a high waist-to-hip ratio was associated significantly with Barrett's esophagus only in whites, but not in blacks or Hispanics.

Gastroesophageal reflux disease symptoms, hiatus hernia, or gastroesophageal valve flap grade could not account for the association.

Dr Kramer's team concludes, "High waist-to-hip ratio, but not body mass index , is associated with a significant increase in the risk of Barrett's esophagus, especially long-segment Barrett's esophagus and in whites."

"The association is not caused by gastroesophageal reflux disease symptoms or hiatus hernia."

Clin Gastroenterol Hepatol 2013: 11(4): 373-381
26 March 2013

Go to top of page Email this page Email this page to a colleague

 05 December 2016 
Disease mangement in IBD
 05 December 2016 
New biomarkers for IBD diagnosis
 05 December 2016 
Reducing hospitalization in IBD
 02 December 2016 
Hep E in acute liver failure
 02 December 2016 
Occurrence and severity of alcoholic hepatitis
 02 December 2016 
Food antigen in active eosinophilic esophagitis
 01 December 2016 
Iron deficiency in anemic ulcerative colitis patients
 01 December 2016 
Prognostic factors after paracetamol-induced liver failure
 01 December 2016 
Factors that influence colorectal cancer screening findings
 30 November 2016 
Certolizumab pegol in Crohn's disease
 30 November 2016 
Genetic risk of Crohn's in chronic granulomatous disease
 30 November 2016 
Rifaximin in diarrhea-predominant IBS
 29 November 2016 
Assessing liver steatosis
 29 November 2016 
Treating Zenker's diverticulum
 29 November 2016 
Colorectal cancer surveillance in ulcerative colitis
 28 November 2016 
Complications in celiac disease
 28 November 2016 
Monitoring IBD with mobile technology
 28 November 2016 
Reducing warfarin-related upper GI bleeds
 25 November 2016 
Metal vs plastic stents for pancreatic cancer surgery
 25 November 2016 
Yoga and IBS therapy 
 25 November 2016 
Colorectal cancer screening issues
 24 November 2016 
Partner burden in celiac disease
 24 November 2016 
Fusobacterium nucleatum for colorectal cancer prognosis
 24 November 2016 
PPIS and gastric cancer risk
 23 November 2016 
Diagnosing autoimmune pancreatitis
 23 November 2016 
Readmissions in cirrhosis
 23 November 2016 
Quality assurance standards for colonoscopy
 22 November 2016 
Fatigue in IBD
 22 November 2016 
PPIs and C. diff in ICU 
 22 November 2016 
Bile acid diarrhea in function bowel disorder with diarrhea
 21 November 2016 
Financial incentives and colorectal cancer screening
 21 November 2016 
Pain after endoscopic resection of gastric tumors
 21 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 18 November 2016 
Colorectal cancer risk and self-reported family history
 18 November 2016 
Ustekinumab in Crohn’s disease
 18 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 17 November 2016 
Risk of overweight in infants
 17 November 2016 
Moderate alcohol consumption and NAFLD
 17 November 2016 
Liver-related specialty care in patients with Hep C
 16 November 2016 
PPI therapy in liver disease
 16 November 2016 
Education in Gastroenterology fellowship
 16 November 2016 
Paternal preconceptional use of anti-TNF-α agents
 15 November 2016 
Novel treatment of NASH 
 15 November 2016 
Physician perspectives on Hep C management
 15 November 2016 
Contraceptives and ulcerative colitis
 14 November 2016 
Cardiovascular risk in NAFLD 
 14 November 2016 
Vit D and NAFLD
 14 November 2016 
Malignancy risk in IBD 
 11 November 2016 
Treatment of Hep C along with opioid agonist therapy
 11 November 2016 
Diabetes and liver cancer risk in Hep C cirrhosis
 11 November 2016 
Biomarker of cirrhosis progression
 10 November 2016 
Testosterone levels and cirrhosis outcomes in men
 10 November 2016 
Improving bowel quality before colonoscopy
 10 November 2016 
Fecal microbiota transplantation and CDI episodes
 09 November 2016 
Minimizing costs of esophagogastroduodenoscopy and colonoscopy
 09 November 2016 
Risk of TB in IBD patients receiving therapy
 09 November 2016 
Liver transplant wait-list and mortality in infants
 08 November 2016 
NSAIDS and risk of Barrett’s
 08 November 2016 
Ferritin levels and NAFLD mortality
 08 November 2016 
Alarms in the diagnosis of colorectal cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us